FBLG (FibroBiologics) OCF Margin %: 0.00% (As of Mar. 2026)


FBLG FibroBiologics Inc FBLG
13 GF Score
Price $0.83
! 3 Warning Signs
View Full Analysis

What is FibroBiologics OCF Margin %?

FibroBiologics FBLG +12.31% 13 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates FBLG with a GF Score™ of 13/100. The stock has 3 warning signs investors should review. Among 959 Biotechnology companies, FibroBiologics ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. FibroBiologics's Cash Flow from Operations for the three months ended in Mar. 2026 was $-4.36 Mil. FibroBiologics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, FibroBiologics's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, FibroBiologics's current OCF Yield % is -357.99%.

The historical rank and industry rank for FibroBiologics's OCF Margin % or its related term are showing as below:


FBLG's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

FibroBiologics OCF Margin % Related Terms

FibroBiologics OCF Margin % Historical Data

* Premium members only.

The historical data trend for FibroBiologics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FibroBiologics OCF Margin % Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
0.00 0.00 0.00 0.00 0.00

FibroBiologics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FBLG
13GF Score
FibroBiologics Inc FBLG
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

FibroBiologics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

FibroBiologics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-16.394/0
= %

FibroBiologics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-4.364/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
FibroBiologics (FBLG) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on FibroBiologics and its competitors. According to the industry distribution chart, FibroBiologics ranks #999999 out of 959 companies in the Biotechnology industry.
Is FibroBiologics' OCF Margin % too high?
FibroBiologics' current OCF Margin % is 0.00%. Based on the distribution chart, FibroBiologics ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, FibroBiologics has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does FibroBiologics' OCF Margin % compare to BGMS and AIM?
According to the Biotechnology industry distribution chart, FibroBiologics ranks #999999 out of 959 companies for OCF Margin %. This places FibroBiologics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on FibroBiologics and its competitors. FibroBiologics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FibroBiologics stock overvalued right now?
FibroBiologics (FBLG) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. FibroBiologics' overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For FibroBiologics (FBLG), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FibroBiologics Business Description

Address 455 East Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
13GF Score

Get the complete analysis for FBLG

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.83
Price